John W. Villiger
Director/Miembro de la Junta en Auckland UniServices Ltd. .
Cargos activos de John W. Villiger
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Auckland UniServices Ltd.
Auckland UniServices Ltd. Investment ManagersFinance Founded in 1988, Auckland UniServices Ltd is a venture capital arm of University of Auckland , New Zealand founded in 1988. The Firm headquartered in New Zealand. | Director/Miembro de la Junta | - | - |
Historial de carrera de John W. Villiger
Antiguos cargos conocidos de John W. Villiger.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
SYNTARA LIMITED | Director/Miembro de la Junta | 01/11/2006 | 19/09/2013 |
Independent Dir/Board Member | 17/06/2011 | 19/09/2013 | |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | - | - |
THE MEDICINES COMPANY | Fundador | 31/07/1996 | - |
Corporate Officer/Principal | 31/07/1996 | - | |
Proacta, Inc.
Proacta, Inc. BiotechnologyHealth Technology Proacta, Inc. develops drugs to treat cancer. It is developing a new generation of hypoxia-activated prodrug compounds to treat cancer. The firm’s lead product PR610, is a proprietary, hypoxia-activated prodrug with potential antineoplastic activity. The company was founded in 2001 by William A. Denny, Amato J. Giaccia, William Robert Wilson and Martin J. Brown and is headquartered in La Jolla, CA. | Director/Miembro de la Junta | 01/01/2004 | 23/02/2010 |
Presidente | 23/02/2010 | - |
Formación de John W. Villiger.
University of Otago | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 4 |
Nueva Zelanda | 3 |
Australia | 2 |
Operativa
Director/Board Member | 3 |
Corporate Officer/Principal | 2 |
Doctorate Degree | 1 |
Sectorial
Health Technology | 5 |
Consumer Services | 2 |
Finance | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
SYNTARA LIMITED | Health Technology |
Empresas privadas | 4 |
---|---|
Proacta, Inc.
Proacta, Inc. BiotechnologyHealth Technology Proacta, Inc. develops drugs to treat cancer. It is developing a new generation of hypoxia-activated prodrug compounds to treat cancer. The firm’s lead product PR610, is a proprietary, hypoxia-activated prodrug with potential antineoplastic activity. The company was founded in 2001 by William A. Denny, Amato J. Giaccia, William Robert Wilson and Martin J. Brown and is headquartered in La Jolla, CA. | Health Technology |
The Medicines Co.
The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Auckland UniServices Ltd.
Auckland UniServices Ltd. Investment ManagersFinance Founded in 1988, Auckland UniServices Ltd is a venture capital arm of University of Auckland , New Zealand founded in 1988. The Firm headquartered in New Zealand. | Finance |
- Bolsa de valores
- Insiders
- John W. Villiger
- Experiencia